Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months – FirstWord Pharma
Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months FirstWord Pharma ‘Game changer’ experimental drug doubles survival time for pancreatic cancer, trial shows CBC ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib …